In the world of cancer care, the only constant is change.
Every year, novel therapies emerge and research generates new discoveries that help to redefine cancer care. Healthcare policy and reimbursement also shift perennially, rewriting the rules by which providers manage the business of oncology. And each year, broader industry restructuring and democratization of high-end capabilities reshape the traditional roles of academic and community providers. The remaking of these long-established roles is not a story of divergence but rather of convergence.